KAINOS MEDICINE, INC. Logo

KAINOS MEDICINE, INC.

Develops small molecule therapeutics for neurodegenerative, infectious, and oncological diseases.

284620 | KO

Overview

Corporate Details

ISIN(s):
KR7284620002
LEI:
Country:
South Korea
Address:
경기도 성남시 분당구 대왕판교로 700 코리아바이오파크 제3층 제에이-301호 일부, 성남시

Description

Kainos Medicine, Inc. is a clinical-stage research and development company specializing in the discovery of novel small molecule therapeutics. The company's primary focus is on addressing unmet medical needs in neurodegenerative disorders, infectious diseases, and oncology. Its drug pipeline includes candidates for the treatment of conditions such as Parkinson's disease, Multiple System Atrophy (MSA), AIDS, and various cancers. Kainos Medicine is dedicated to developing innovative treatments for these challenging diseases.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-03-27 00:00
투자판단관련주요경영사항(임상시험계획변경승인신청)
Korean 11.7 KB
2025-03-21 00:00
증권발행결과(자율공시) (제3자배정 유상증자)
Korean 7.0 KB
2025-03-21 00:00
주권매매거래정지 (관리종목지정사유발생)
Korean 4.7 KB
2025-03-21 00:00
감사보고서제출
Korean 26.2 KB
2025-03-21 00:00
사업보고서 (2024.12)
Korean 453.2 KB
2025-03-18 00:00
의결권대리행사권유참고서류
Korean 139.7 KB
2025-03-14 00:00
주주총회소집결의
Korean 11.2 KB
2025-03-14 00:00
주주총회소집공고
Korean 133.3 KB
2025-03-13 00:00
[기재정정]주요사항보고서(유상증자결정)
Korean 75.6 KB
2025-03-12 00:00
[기재정정]주요사항보고서(유상증자결정)
Korean 56.5 KB
2025-03-04 00:00
[기재정정]주요사항보고서(유상증자결정)
Korean 84.7 KB
2025-03-04 00:00
주요사항보고서(유상증자결정)
Korean 54.8 KB
2025-03-04 00:00
[기재정정]주요사항보고서(유상증자결정)
Korean 48.7 KB
2025-03-04 00:00
[기재정정]주요사항보고서(유상증자결정)
Korean 56.9 KB
2025-02-28 00:00
내부결산시점관리종목지정ㆍ형식적상장폐지ㆍ상장적격성실질심사사유발생
Korean 23.4 KB

Automate Your Workflow. Get a real-time feed of all KAINOS MEDICINE, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for KAINOS MEDICINE, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for KAINOS MEDICINE, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.